Skip to content

Study on the Protective Effect of RIPC in Patients Undergoing Cardiac Surgery.

Study on the Protective Effect of RIPC in Patients Undergoing Cardiac Surgery.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04433468
Enrollment
60
Registered
2020-06-16
Start date
2020-09-01
Completion date
2021-03-31
Last updated
2022-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Brief summary

To observe the effect of RIPC on the function of vital organs after cardiac surgery, and to explore its possible mechanism.

Interventions

DEVICERIPC

The tourniquet attached to the upper limb was inflated and blocked for 5 minutes, then deflated for 5 minutes to restore blood flow and induce ischemic preconditioning.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with aortic valve, mitral valve, tricuspid valve, ascending aortic disease and coronary atherosclerosis who were admitted to hospital for elective valve repair, replacement, artificial vascular replacement or coronary artery bypass grafting. * age 18-80 years old. * No restriction on gender. * ASA grade II\ III. * NYHAII\ III level. * the patient or his family member has signed the informed consent form for the clinical trial

Exclusion criteria

* those who are disabled in the selected test. * less than 5 years of education. * The preoperative left ventricular ejection fraction ((LVEF)) was less than 40%. * Myocardial infarction occurred in nearly one month. * malignant tumor, hematological disease, severe liver and kidney dysfunction, recent severe infection, etc. * History of nervous system, immune system and mental illness. * recent operation history of heart, brain, lung, liver, kidney and other important organs

Design outcomes

Primary

MeasureTime frameDescription
The incidence of acute renal injury after operationwithin 7 days after operationAccording to the (KDIGO) guidelines for improving the prognosis of renal disease
The incidence of postoperative deliriumwithin 7 days after operationCAM score greater than 22

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026